Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Abliva Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0129M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | 0.003M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.0054M |
| September 30, 2021 | 0.0098M |
| June 30, 2021 | 0.0021M |
| March 31, 2021 | |
| December 31, 2020 | 0.0129M |
| September 30, 2020 | |
| June 30, 2020 | 0.01M |
| March 31, 2020 | 0.0008M |
| December 31, 2019 | 0.0051M |
| September 30, 2019 | |
| June 30, 2019 | 0.009M |
| March 31, 2019 | |
| December 31, 2018 | 0.0006M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 0.003M |
| December 31, 2016 | 0.0015M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.2971M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 1.03M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 0.8141M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.8237M |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0008M
Minimum
Mar 2020
0.0129M
Maximum
Dec 2020
0.0069M
Average
0.0054M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Oncopeptides AB | 0.26M |
| BioInvent International AB | 1.23M |
| Hansa Biopharma AB | 4.689M |
| BioArctic AB | 4.673M |
| Camurus AB | 46.21M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.414M |
| Total Expenses (Quarterly) | 2.413M |
| EPS Diluted (Quarterly) | -0.0019 |
| Enterprise Value | 11.86M |
| Earnings Yield | -84.68% |
| Normalized Earnings Yield | -84.91 |